Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024
The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033.
This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics.
At HBI 2024, the panel ‘Laboratory Diagnostics – Growth Beyond Consolidation‘ brought together industry experts Dr. Stephan Rau from McDermott, Will & Emery, Joe Stringer, Executive Chairman of Automata, Jean-Francois Pomerol, CEO & Co-Founder of Tribun Health, and Jérôme Thill, Partner at Horasis. AI featured prominently in discussions, particularly regarding the future of lab automation and the rise of remote ‘dark labs’—fully automated diagnostic laboratories.
The role of AI in clinical diagnostics
Artificial intelligence (AI) holds the potential to significantly improve the accuracy, speed, and efficiency of clinical diagnostics by analysing medical images and processing extensive patient data such as electronic health records, medical histories, and lab results.
Stringer underscored the need for innovation to tackle industry challenges, advocating for regulatory advancements and a shift in mindset among lab operators.
Jean-Francois Pomerol emphasised the pivotal role of automation in addressing workforce shortages across various sectors, particularly in data-driven diagnostics, thereby shaping the future landscape of healthcare.
The potential of at-home testing
The COVID-19 pandemic spurred the adoption of at-home diagnostics, prompting companies and new entrants to develop advanced products specifically for COVID-19 detection. This surge in demand catalysed further growth in the market.
Stringer highlighted the burgeoning potential of at-home testing, acknowledging its rapid growth despite current technological limitations.
“At-home testing represents one of the fastest-growing sectors in diagnostics. While there is room for technological improvement, its potential is considerable. Nonetheless, it remains in its early stages.”
Labs Consolidation
Consolidation in the lab diagnostics market is on the rise, driven by increasing mergers and acquisitions. Experts predict this trend will continue, fuelled by cost-cutting and heightened competition. Recent reports indicate a doubling in M&A activity within the sector, with smaller laboratories facing acquisition or consolidation while larger entities grow even larger.
Jérôme Thill highlighted that larger players can enhance their role in the medical chain through consolidation, emphasising the industry’s cautious approach to automation for reliable and proximal lab results.
“The takeaway from consolidation is the capacity of big players to have a more productive role and demonstrate their effectiveness in the medical chain. There is a structural reluctance within the ecosystem towards automation. Doctors want results directly from labs and need full reliability, confidence, and proximity.”
Stringer underscored the growing international opportunities amid national market consolidations, citing regulatory challenges that automation could help address. He also acknowledged the burgeoning potential of at-home testing despite its current technological limitations.
We would welcome your thoughts on this story. Email your views to Rakshitha Narasimhan or call 0207 183 3779.
